Citations for
1APELA, APLN
Elabela and Apelin actions in healthy and pathological pregnancies.
Eberlé D, Marousez L, Hanssens S, Knauf C, Breton C, Deruelle P, Lesage J.
Cytokine Growth Factor Rev 46:45-53. doi: 10.1016/j.cytogfr.2019.03.003. Epub 2019 Mar 16. Review. 2019
2APELA, APLN
Apelin and Elabela/Toddler; double ligands for APJ/Apelin receptor in heart development, physiology, and pathology.
Kuba K, Sato T, Imai Y, Yamaguchi T.
Peptides 111:62-70. doi: 10.1016/j.peptides.2018.04.011. Epub 2018 Apr 21. Review. 2019
3APELA, APLN, GPR25
The orphan G protein-coupled receptor 25 (GPR25) is activated by Apelin and Apela in non-mammalian vertebrates.
Zhang J, Wan Y, Fang C, Chen J, Ouyang W, Li J, Wang Y.
Biochem Biophys Res Commun 501(2):408-414. doi: 10.1016/j.bbrc.2018.04.229. Epub 2018 May 11. 2018
4APLN, APLNR
Effect of the spinal apelin‑APJ system on the pathogenesis of chronic constriction injury‑induced neuropathic pain in rats.
Xiong Q, He W, Wang H, Zhou J, Zhang Y, He J, Yang C, Zhang B.
Mol Med Rep 16(2):1223-1231. doi: 10.3892/mmr.2017.6734. Epub 2017 Jun 9. 2017
5APELA, APLN, APLNR
Structural Basis for Apelin Control of the Human Apelin Receptor.
Ma Y, Yue Y, Ma Y, Zhang Q, Zhou Q, Song Y, Shen Y, Li X, Ma X, Li C, Hanson MA, Han GW, Sickmier EA, Swaminath G, Zhao S, Stevens RC, Hu LA, Zhong W, Zhang M, Xu F.
Structure 25(6):858-866.e4. doi: 10.1016/j.str.2017.04.008. Epub 2017 May 18. 2017
6APLN
Hypoxic Exercise Training Promotes apelin/APJ Expression in Skeletal Muscles of High Fat Diet-Induced Obese Mice.
Ji W, Gong L, Wang J, He H, Zhang Y.
Protein Pept Lett 24(1):64-70. doi: 10.2174/0929866524666161111111726. 2017
7APELA, APLN
Characterization of apela, a novel endogenous ligand of apelin receptor, in the adult heart.
Perjés Á, Kilpiö T, Ulvila J, Magga J, Alakoski T, Szabó Z, Vainio L, Halmetoja E, Vuolteenaho O, Petäjä-Repo U, Szokodi I, Kerkelä R.
Basic Res Cardiol 111(1):2. doi: 10.1007/s00395-015-0521-6. Epub 2015 Nov 26. 2016
8APLN, APLNR
Apelin (APLN) and Apelin Receptor (APLNR) in Human Ovary: Expression, Signaling, and Regulation of Steroidogenesis in Primary Human Luteinized Granulosa Cells.
Roche J, Ramé C, Reverchon M, Mellouk N, Cornuau M, Guerif F, Froment P, Dupont J.
Biol Reprod 95(5):104. Epub 2016 Sep 28. 2016
9APLN, APLNR
Hypoxia induces the proliferation of endothelial progenitor cells via upregulation of Apelin/APLNR/MAPK signaling.
Zhang J, Liu Q, Fang Z, Hu X, Huang F, Tang L, Zhou S.
Mol Med Rep 13(2):1801-6. doi: 10.3892/mmr.2015.4691. Epub 2015 Dec 17. 2016
10APLN, APLNR
New structural insights into the apelin receptor: identification of key residues for apelin binding.
Gerbier R, Leroux V, Couvineau P, Alvear-Perez R, Maigret B, Llorens-Cortes C, Iturrioz X.
FASEB J 29(1):314-22. doi: 10.1096/fj.14-256339. Epub 2014 Oct 30. 2015
11APLN
Apelin attenuates oxidative stress in human adipocytes.
Than A, Zhang X, Leow MK, Poh CL, Chong SK, Chen P.
J Biol Chem 289(6):3763-74. doi: 10.1074/jbc.M113.526210. Epub 2013 Dec 20. 2014
12APLN, ATF4
Apelin is transcriptionally regulated by ER stress-induced ATF4 expression via a p38 MAPK-dependent pathway.
Jeong K, Oh Y, Kim SJ, Kim H, Park KC, Kim SS, Ha J, Kang I, Choe W.
Apoptosis 19(9):1399-410. doi: 10.1007/s10495-014-1013-0. 2014
13APLN, APLNR
Identification of serine 348 on the apelin receptor as a novel regulatory phosphorylation site in apelin-13-induced G protein-independent biased signaling.
Chen X, Bai B, Tian Y, Du H, Chen J.
J Biol Chem 289(45):31173-87. doi: 10.1074/jbc.M114.574020. Epub 2014 Sep 30. 2014
14APLN, APLNR
Apelin and its receptor APJ in cardiovascular diseases.
Yu XH, Tang ZB, Liu LJ, Qian H, Tang SL, Zhang DW, Tian GP, Tang CK.
Clin Chim Acta 428:1-8. doi: 10.1016/j.cca.2013.09.001. Epub 2013 Sep 18. Review. 2014
15APLN, EGR1, SPP1
Apelin-13-induced proliferation and migration induced of rat vascular smooth muscle cells is mediated by the upregulation of Egr-1.
Liu QF, Yu HW, You L, Liu MX, Li KY, Tao GZ.
Biochem Biophys Res Commun 439(2):235-40. doi: 10.1016/j.bbrc.2013.08.051. Epub 2013 Aug 22. 2013
16APLN
Apelin-13 regulates proliferation, migration and survival of retinal Müller cells under hypoxia.
Lu Q, Jiang YR, Qian J, Tao Y.
Diabetes Res Clin Pract 99(2):158-67. doi: 10.1016/j.diabres.2012.09.045. Epub 2013 Jan 15. 2013
17APLN
Apelin-13 induces proliferation, migration, and collagen I mRNA expression in human RPE cells via PI3K/Akt and MEK/Erk signaling pathways.
Qin D, Zheng XX, Jiang YR.
Mol Vis 19:2227-36. eCollection 2013. 2013
18ACE2, APLN
Apelin is a positive regulator of ACE2 in failing hearts.
Sato T, Suzuki T, Watanabe H, Kadowaki A, Fukamizu A, Liu PP, Kimura A, Ito H, Penninger JM, Imai Y, Kuba K.
J Clin Invest 123(12):5203-11. doi: 10.1172/JCI69608. Epub 2013 Nov 1. 2013
19APLN
Apelin ameliorates TNF-α-induced reduction of glycogen synthesis in the hepatocytes through G protein-coupled receptor APJ.
Chu J, Zhang H, Huang X, Lin Y, Shen T, Chen B, Man Y, Wang S, Li J.
PLoS One 8(2):e57231. doi: 10.1371/journal.pone.0057231. Epub 2013 Feb 21. 2013
20APLN
Inhibition of apelin expression by BMP signaling in endothelial cells.
Poirier O, Ciumas M, Eyries M, Montagne K, Nadaud S, Soubrier F.
Am J Physiol Cell Physiol 303(11):C1139-45. doi: 10.1152/ajpcell.00168.2012. Epub 2012 Aug 15. 2012
21APLN
Apelin inhibits adipogenesis and lipolysis through distinct molecular pathways.
Than A, Cheng Y, Foh LC, Leow MK, Lim SC, Chuah YJ, Kang Y, Chen P.
Mol Cell Endocrinol 362(1-2):227-41. doi: 10.1016/j.mce.2012.07.002. Epub 2012 Jul 26. 2012
22APLN
APELIN promotes hematopoiesis from human embryonic stem cells.
Yu QC, Hirst CE, Costa M, Ng ES, Schiesser JV, Gertow K, Stanley EG, Elefanty AG.
Blood 119(26):6243-54. doi: 10.1182/blood-2011-12-396093. Epub 2012 May 18. 2012
23APLN, OPRK1
Heterodimerization of human apelin and kappa opioid receptors: roles in signal transduction.
Li Y, Chen J, Bai B, Du H, Liu Y, Liu H.
Cell Signal 24(5):991-1001. doi: 10.1016/j.cellsig.2011.12.012. Epub 2011 Dec 20. 2012
24APLN
Apelin deficiency accelerates the progression of amyotrophic lateral sclerosis.
Kasai A, Kinjo T, Ishihara R, Sakai I, Ishimaru Y, Yoshioka Y, Yamamuro A, Ishige K, Ito Y, Maeda S.
PLoS One 6(8):e23968. doi: 10.1371/journal.pone.0023968. Epub 2011 Aug 24. 2011
25APLN
Lower serum apelin levels in women with polycystic ovary syndrome.
Chang CY, Tsai YC, Lee CH, Chan TF, Wang SH, Su JH.
Fertil Steril 95(8):2520-3.e1-2. doi: 10.1016/j.fertnstert.2011.04.044. Epub 2011 May 14. 2011
26APLN, APLNR
The apelinergic system in the developing lung: expression and signaling.
Piairo P, Moura RS, Nogueira-Silva C, Correia-Pinto J.
Peptides 32(12):2474-83. doi: 10.1016/j.peptides.2011.10.010. Epub 2011 Oct 12. 2011
27APL, APLN, APLNR
Apelin and APJ regulation in adipose tissue and skeletal muscle of type 2 diabetic mice and humans.
Dray C, Debard C, Jager J, Disse E, Daviaud D, Martin P, Attané C, Wanecq E, Guigné C, Bost F, Tanti JF, Laville M, Vidal H, Valet P, Castan-Laurell I.
Am J Physiol Endocrinol Metab 298(6):E1161-9. Epub 2010 Mar 16.PMID: 20233941 2010
28ACE2, APLN
Apelin and ACE2 in cardiovascular disease.
Kalea AZ, Batlle D.
Curr Opin Investig Drugs 11(3):273-82. Review. 2010
29APLN
Structural insight into G-protein coupled receptor binding by apelin.
Langelaan DN, Bebbington EM, Reddy T, Rainey JK.
Biochemistry 48(3):537-48.PMID: 19123778 2009
30APLN, APLNR
Apelin and its receptor APJ in human aortic valve stenosis.
Peltonen T, Näpänkangas J, Vuolteenaho O, Ohtonen P, Soini Y, Juvonen T, Satta J, Ruskoaho H, Taskinen P.
J Heart Valve Dis 18(6):644-52.PMID: 20099713 2009
31APLN, APLNR
Abnormal fluid homeostasis in apelin receptor knockout mice.
Roberts EM, Newson MJ, Pope GR, Landgraf R, Lolait SJ, O'Carroll AM.
J Endocrinol 202(3):453-62. Epub 2009 Jul 3.PMID: 19578099 2009
32APLN
A putative role for apelin in the etiology of obesity.
Rayalam S, Della-Fera MA, Krieg PA, Cox CM, Robins A, Baile CA.
Biochem Biophys Res Commun 368(3):815-9. Epub 2008 Feb 12. Review. 2008
33APLN
The hepatic apelin system: a new therapeutic target for liver disease.
Principe A, Melgar-Lesmes P, Fernández-Varo G, del Arbol LR, Ros J, Morales-Ruiz M, Bernardi M, Arroyo V, Jiménez W.
Hepatology 48(4):1193-201.PMID: 1881663 2008
34APLN
Low plasma apelin levels in newly diagnosed type 2 diabetes mellitus.
Erdem G, Dogru T, Tasci I, Sonmez A, Tapan S.
Exp Clin Endocrinol Diabetes 116(5):289-92.PMID: 18484561 2008
35APLN
Apelin-13 and apelin-36 exhibit direct cardioprotective activity against ischemia-reperfusion injury.
Simpkin JC, Yellon DM, Davidson SM, Lim SY, Wynne AM, Smith CC.
Basic Res Cardiol 102(6):518-28. Epub 2007 Aug 13.PMID: 17694254 2007
36APLN
Apelin is a potent activator of tumour neoangiogenesis.
Sorli SC, Le Gonidec S, Knibiehler B, Audigier Y.
Oncogene 26(55):7692-9. Epub 2007 Jun 11.PMID: 17563744 2007
37APLN
Apelin stimulates myosin light chain phosphorylation in vascular smooth muscle cells.
Hashimoto T, Kihara M, Ishida J, Imai N, Yoshida S, Toya Y, Fukamizu A, Kitamura H, Umemura S.
Arterioscler Thromb Vasc Biol 26(6):1267-72. Epub 2006 Mar 23. 2006
38APLN
Apelin, a newly identified adipokine up-regulated by insulin and obesity.
Boucher J, Masri B, Daviaud D, Gesta S, Guigne C, Mazzucotelli A, Castan-Laurell I, Tack I, Knibiehler B, Carpene C, Audigier Y, Saulnier-Blache JS, Valet P.
Endocrinology 146(4):1764-71. Epub 2005 Jan 27. 2005
39APLN
Apelin, a new enteric peptide: localization in the gastrointestinal tract, ontogeny, and stimulation of gastric cell proliferation and of cholecystokinin secretion.
Wang G, Anini Y, Wei W, Qi X, OCarroll AM, Mochizuki T, Wang HQ, Hellmich MR, Englander EW, Greeley GH Jr.
Endocrinology 145(3):1342-8. Epub 2003 Dec 11. 2004
40APLN
Apelin is a novel angiogenic factor in retinal endothelial cells.
Kasai A, Shintani N, Oda M, Kakuda M, Hashimoto H, Matsuda T, Hinuma S, Baba A.
Biochem Biophys Res Commun 325(2):395-400. 2004
41APLN, APLNR
Circulating and cardiac levels of apelin, the novel ligand of the orphan receptor APJ, in patients with heart failure.
Foldes G, Horkay F, Szokodi I, Vuolteenaho O, Ilves M, Lindstedt KA, Mayranpaa M, Sarman B, Seres L, Skoumal R, Lako-Futo Z, deChatel R, Ruskoaho H, Toth M.
Biochem Biophys Res Commun 308(3):480-5. 2003
42APLN, APLNR
Novel role for the potent endogenous inotrope apelin in human cardiac dysfunction.
Chen MM, Ashley EA, Deng DX, Tsalenko A, Deng A, Tabibiazar R, Ben-Dor A, Fenster B, Yang E, King JY, Fowler M, Robbins R, Johnson FL, Bruhn L, McDonagh T, Dargie H, Yakhini Z, Tsao PS, Quertermous T.
Circulation 108(12):1432-9. Epub 2003 Sep 8. 2003
43APLN, APLNR
Pharmacological and immunohistochemical characterization of the APJ receptor and its endogenous ligand apelin.
Medhurst AD, Jennings CA, Robbins MJ, Davis RP, Ellis C, Winborn KY, Lawrie KW, Hervieu G, Riley G, Bolaky JE, Herrity NC, Murdock P, Darker JG.
J Neurochem 84(5):1162-72.PMID: 12603839 2003
44APLN
Molecular properties of apelin: tissue distribution and receptor binding.
Kawamata Y, Habata Y, Fukusumi S, Hosoya M, Fujii R, Hinuma S, Nishizawa N, Kitada C, Onda H, Nishimura O, Fujino M.
Biochim Biophys Acta 1538(2-3):162-71. 2001
45APLN
Apelin, the natural ligand of the orphan receptor APJ, is abundantly secreted in the colostrum.
Habata Y, Fujii R, Hosoya M, Fukusumi S, Kawamata Y, Hinuma S, Kitada C, Nishizawa N, Murosaki S, Kurokawa T, Onda H, Tatemoto K, Fujino M.
Biochim Biophys Acta 1452(1):25-35. 1999
46APLN
Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor.
Tatemoto K, Hosoya M, Habata Y, Fujii R, Kakegawa T, Zou MX, Kawamata Y, Fukusumi S, Hinuma S, Kitada C, Kurokawa T, Onda H, Fujino M.
Biochem Biophys Res Commun 251(2):471-6. 1998